Cramer: Mylan's EpiPen represents a big glitch in the system By: CNBC.com News August 25, 2016 at 19:11 PM EDT Jim Cramer says executive embarrassment and presidential candidate tweets won’t solve the EpiPen problem, competition is needed. Read More >> Related Stocks: Mylan Sanofi-Aventis S.A. ADR